Prognostic utility of inflammation-based biomarkers, neutrophil–lymphocyte ratio and change in neutrophil–lymphocyte ratio, in surgically resected lung cancers

BACKGROUND/OBJECTIVE: Given the poor overall survival (OR) and progression-free survival (PFS) rates for lung cancers managed with surgical resection, there is a need to identify the prognostic markers that would improve the risk stratification of patients with operable lung cancer to inform treatme...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Thorac Med
Hlavní autoři: Thompson, Daniel, Perry, Luke A., Renouf, Jesse, Vodanovich, Domagoj, Hong Lee, Adele Hwee, Dimiri, Jahan, Wright, Gavin
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer - Medknow 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8109682/
https://ncbi.nlm.nih.gov/pubmed/34012481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/atm.ATM_382_20
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky